USANA Health Sciences (NYSE: USNA) reported Q1 EPS of $1.15, $0.01 better than the analyst estimate of $1.14. Revenue for the quarter came in at $273 million versus the consensus estimate of $267.31 million.

GUIDANCE:

USANA Health Sciences sees FY2022 EPS of $5.00-$5.70, versus the consensus of $5.46. USANA Health Sciences sees FY2022 revenue of $1.1-1.2 billion, versus the consensus of $1.14 billion.

For earnings history and earnings-related data on USANA Health Sciences (USNA) click here.